AB 1790 California Assembly · 2017-2018 Regular Session

Valley Fever Education, Early Diagnosis, and Treatment Act.

Summary
Existing law requires the State Department of Public Health to establish a list of reportable communicable and noncommunicable diseases and conditions and specify the timeliness requirements related to the reporting of each disease and condition. Existing law requires the department to develop information about various communicable diseases, including hepatitis C and meningococcal disease, and to make the information available to the public. Existing law also supports research into the development of a vaccine to protect against valley fever (coccidioidomycosis) . This bill would establish the Valley Fever Education, Early Diagnosis, and Treatment Act. This bill would, among other things, require the department to conduct a valley fever awareness campaign to communicate with local health jurisdictions, providers, and the public about valley fever, as described. The bill would authorize the department to award grants or enter into contracts to perform activities related to the awareness campaign, as specified. Those provisions would become inoperative on January 1, 2021.
Bill status signed all 5 stages cleared
Introduction
Jan 2018
Committee Review
Aug 2018
Assembly Passage
May 2018
Senate Passage
Aug 2018
Signed into Law
Sep 2018
Introduced Jan 8, 2018 Signed Sep 11, 2018
Floor votes · Senate Aug 27, 2018 · Assembly Aug 30, 2018

How they voted

320
Passed
Total votes 32
Aug 27, 2018
D Democratic21
21 Yea
100% Yea
R Republican11
11 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
40
Key actions
13
Committee
12
Amendments
9
Sep 11, 2018
Signed into law
Approved by the Governor.
legislature
Aug 30, 2018
Assembly · Passed
Assembly Vote: pass (70-0)
assembly
Aug 29, 2018
Lower · Passed
Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 80. Noes 0. Page 6868.).
lower
Aug 27, 2018
Senate · Passed
Senate Vote: pass (32-0)
senate
Aug 27, 2018
Introduced
In Assembly. Concurrence in Senate amendments pending. May be considered on or after August 29 pursuant to Assembly Rule 77.
lower
Aug 23, 2018
Upper · Passed
Read third time and amended. Ordered to second reading.
upper
Aug 22, 2018
Upper · Passed
From committee: That the measure be returned to Senate Floor for consideration. (Ayes 9. Noes 0.) (August 22)
upper
Aug 20, 2018
Committee
Re-referred to Com. on HEALTH pursuant to Senate Rule 29.10(b).
upper
Aug 20, 2018
Committee
Re-referred to Com. on RLS. pursuant to Senate Rule 29.10(b).
upper
Aug 16, 2018
Upper · Passed
Read third time and amended. Ordered to second reading.
upper
Jul 5, 2018
Introduced
In Assembly. Concurrence in Senate amendments pending. May be considered on or after August 3 pursuant to Assembly Rule 77.
lower
Jul 2, 2018
Upper · Passed
From committee: Be ordered to second reading pursuant to Senate Rule 28.8.
upper
Jun 19, 2018
Upper · Passed
Read second time and amended. Re-referred to Com. on APPR.
upper
Jun 18, 2018
Upper · Passed
From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 8. Noes 0.) (June 13).
upper
May 30, 2018
Committee
Referred to Com. on HEALTH.
upper
May 9, 2018
Lower · Passed
From committee: Do pass. To Consent Calendar. (Ayes 16. Noes 0.) (May 9).
lower
May 1, 2018
Committee
Re-referred to Com. on APPR.
lower
Apr 26, 2018
Lower · Passed
From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 15. Noes 0.) (April 24).
lower
Apr 23, 2018
Committee
Re-referred to Com. on B. & P.
lower
Apr 19, 2018
Introduced
From committee chair, with author's amendments: Amend, and re-refer to Com. on B. & P. Read second time and amended.
lower
Apr 4, 2018
Committee
Re-referred to Com. on B. & P.
lower
Apr 3, 2018
Introduced
From committee chair, with author's amendments: Amend, and re-refer to Com. on B. & P. Read second time and amended.
lower
Jan 22, 2018
Committee
Referred to Com. on B. & P.
lower
Jan 9, 2018
Lower · Passed
From printer. May be heard in committee February 8.
lower
0 primary · 15 co-sponsors

Sponsors

No sponsor information available.